These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

449 related items for PubMed ID: 8871655

  • 1. DNA vaccination primes MHC class I-restricted, simian virus 40 large tumor antigen-specific CTL in H-2d mice that reject syngeneic tumors.
    Schirmbeck R, Böhm W, Reimann J.
    J Immunol; 1996 Oct 15; 157(8):3550-8. PubMed ID: 8871655
    [Abstract] [Full Text] [Related]

  • 2. Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection.
    Newmaster RS, Mylin LM, Fu TM, Tevethia SS.
    Virology; 1998 May 10; 244(2):427-41. PubMed ID: 9601511
    [Abstract] [Full Text] [Related]

  • 3. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
    Wild J, Grusby MJ, Schirmbeck R, Reimann J.
    J Immunol; 1999 Aug 15; 163(4):1880-7. PubMed ID: 10438922
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunization of mice with the N-terminal (1-272) fragment of simian virus 40 large T antigen (without adjuvants) specifically primes cytotoxic T lymphocytes.
    Schirmbeck R, Zerrahn J, Kuhröber A, Deppert W, Reimann J.
    Eur J Immunol; 1993 Jul 15; 23(7):1528-34. PubMed ID: 8325328
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Vaccination with T cell receptor peptides primes anti-receptor cytotoxic T lymphocytes (CTL) and anergizes T cells specifically recognized by these CTL.
    Kuhröber A, Schirmbeck R, Reimann J.
    Eur J Immunol; 1994 May 15; 24(5):1172-80. PubMed ID: 7514132
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo.
    Schirmbeck R, Melber K, Kuhröber A, Janowicz ZA, Reimann J.
    J Immunol; 1994 Feb 01; 152(3):1110-9. PubMed ID: 8301120
    [Abstract] [Full Text] [Related]

  • 18. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M, Orosz CG, Bach FH.
    J Immunol; 1984 Jun 01; 132(6):3218-25. PubMed ID: 6202778
    [Abstract] [Full Text] [Related]

  • 19. Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo.
    Böhm W, Schirmbeck R, Elbe A, Melber K, Diminky D, Kraal G, van Rooijen N, Barenholz Y, Reimann J.
    J Immunol; 1995 Oct 01; 155(7):3313-21. PubMed ID: 7561024
    [Abstract] [Full Text] [Related]

  • 20. Costimulation provided by DNA immunization enhances antitumor immunity.
    Corr M, Tighe H, Lee D, Dudler J, Trieu M, Brinson DC, Carson DA.
    J Immunol; 1997 Nov 15; 159(10):4999-5004. PubMed ID: 9366427
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.